Thus, silencing RAN translation could be a powerful therapeutic approach for FTD/ALS as well as other neurodegenerative diseases in which RAN translation plays a role (i.e., Huntington’s disease, ataxia, and others)106. This evidence concerns the gene RAN and neurodegenerative disease.